158 related articles for article (PubMed ID: 16878150)
1. Recruitment of insulin receptor substrate-1 and activation of NF-kappaB essential for midkine growth signaling through anaplastic lymphoma kinase.
Kuo AH; Stoica GE; Riegel AT; Wellstein A
Oncogene; 2007 Feb; 26(6):859-69. PubMed ID: 16878150
[TBL] [Abstract][Full Text] [Related]
2. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation.
Liang L; Jiang J; Frank SJ
Endocrinology; 2000 Sep; 141(9):3328-36. PubMed ID: 10965905
[TBL] [Abstract][Full Text] [Related]
4. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
[TBL] [Abstract][Full Text] [Related]
5. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
[TBL] [Abstract][Full Text] [Related]
6. Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes.
Fasshauer M; Klein J; Kriauciunas KM; Ueki K; Benito M; Kahn CR
Mol Cell Biol; 2001 Jan; 21(1):319-29. PubMed ID: 11113206
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic lymphoma kinase: "Ligand Independent Activation" mediated by the PTN/RPTPβ/ζ signaling pathway.
Deuel TF
Biochim Biophys Acta; 2013 Oct; 1834(10):2219-23. PubMed ID: 23777859
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
[TBL] [Abstract][Full Text] [Related]
10. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of pancreatic beta-cell proliferation by growth hormone is glucose-dependent: signal transduction via janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5) with no crosstalk to insulin receptor substrate-mediated mitogenic signalling.
Cousin SP; Hügl SR; Myers MG; White MF; Reifel-Miller A; Rhodes CJ
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):649-58. PubMed ID: 10585851
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
13. ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth.
Motegi A; Fujimoto J; Kotani M; Sakuraba H; Yamamoto T
J Cell Sci; 2004 Jul; 117(Pt 15):3319-29. PubMed ID: 15226403
[TBL] [Abstract][Full Text] [Related]
14. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
[TBL] [Abstract][Full Text] [Related]
15. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin.
Stoica GE; Kuo A; Aigner A; Sunitha I; Souttou B; Malerczyk C; Caughey DJ; Wen D; Karavanov A; Riegel AT; Wellstein A
J Biol Chem; 2001 May; 276(20):16772-9. PubMed ID: 11278720
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.
Perez-Pinera P; Zhang W; Chang Y; Vega JA; Deuel TF
J Biol Chem; 2007 Sep; 282(39):28683-28690. PubMed ID: 17681947
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
[TBL] [Abstract][Full Text] [Related]
19. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E
Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326
[TBL] [Abstract][Full Text] [Related]
20. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]